Global Peptide Drug Conjugate Market USD 1400 Million Opportunity Says Kuick Research In New Study. Delhi, June 05, 2025 ...

The global market for Anticancer Drugs was valued at USD 206090 Million in the year 2024 and is projected to reach a revised size of USD 430540 Million by 2031, growing at a CAGR of 11.3% during the ...

Researchers have discovered that plant-derived phytochemicals and their gut microbiome metabolites control the effectiveness ...

Scientists have discovered that a promising new anticancer medicine currently in development could be made from unknown dangerous compounds. This discovery could overturn over 60 years of chemistry ...

An engineered viral protein enhanced the anticancer function of T cells in mice, suggesting a new strategy to improve ...

As a chemist at Florida State, he pioneered techniques used in the large-scale production of Taxol, a blockbuster anti-cancer agent.

Researchers say, “It turns out SSRIs don’t just make our brains happier; they also make our T cells happier—even while ...

While many kids struggled with isolation during the pandemic, 12-year-old Jacob Heller faced a more personal challenge: his ...

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies. An emerging class of anticancer drugs called EZH2 inhibitors may ...

This review focuses on the anticancer mechanisms of specific medicinal plants and discusses their potential for future therapeutic development. Medicinal plants exert anticancer effects through ...

“This new strategy has a number of advantages compared to previous DR5-targeting strategies and other anticancer immunotherapies,” Professor of Pathology and Laboratory Medicine Xiaowei “George” Xu ...

"Among all former studies on this plant, the most promising activities are found to be its anticancer, antiparasitic and insecticidal activity," researchers noted in a 2015 review paper in the ...